Handelsinvest Investeringsforvaltning Ptc Therapeutics, Inc. Transaction History

Handelsinvest Investeringsforvaltning

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$41.85 - $53.85 $117,180 - $150,780	2,800 Added 2.78%	103,700 $5.21 Million
Q2 2022 Jul 13, 2022	BUY	$25.6 - $45.23 $663,040 - $1.17 Million	25,900 Added 34.53%	100,900 $4.04 Million
Q1 2021 Apr 20, 2021	SELL	$46.8 - $68.92 $234,000 - $344,600	-5,000 Reduced 6.25%	75,000 $3.55 Million
Q4 2020 Jan 25, 2021	BUY	$47.96 - $67.64 $959,200 - $1.35 Million	20,000 Added 33.33%	80,000 $4.88 Million
Q3 2020 Oct 26, 2020	BUY	$45.41 - $57.07 $454,099 - $570,700	10,000 Added 20.0%	60,000 $2.81 Million
Q4 2019 Jan 30, 2020	BUY	$32.22 - $50.07 $966,600 - $1.5 Million	30,000 Added 150.0%	50,000 $2.4 Million
Q2 2019 Aug 08, 2019	BUY	$35.42 - $45.0 $708,400 - $900,000	20,000 New	20,000 $900,000

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.31B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Handelsinvest Investeringsforvaltning, based on Form 13F filings with the SEC.

Stay updated on Handelsinvest Investeringsforvaltning with notifications on news.